| (USD) | Sep 2023 | Y/Y change |
|---|---|---|
| Revenue | 70.00K | — |
| Operating expense | — | — |
| Net income | 115.31K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OTLC returned -30.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -56.2% |
| 1 year | -30.0% |
| 5 years | -75.0% |
| 10 years | -94.8% |
| All-time high | $8,340.00 (Jun 1997) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in OTLC would be worth today ›No. Oncotelic Therapeutics, Inc. has not paid a dividend in the past 12 months.
Oncotelic Therapeutics, Inc. is part of the Healthcare sector.
Oncotelic Therapeutics, Inc. has a market cap of 16.01M USD, based on the latest quote.
